{{Rsnum
|rsid=11986220
|Chromosome=8
|position=127519444
|Orientation=plus
|GMAF=0.1038
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 6.7 | 93.3
| HCB | 5.0 | 10.0 | 85.0
| JPT | 2.6 | 20.5 | 76.9
| YRI | 1.7 | 13.8 | 84.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 5.0 | 10.0 | 85.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{doi|10.1371|journal.pgen.1000597}} PLOS reports that [[rs11986220]] in [[8q24]] resides within a FoxA1 binding site, with the prostate cancer risk allele facilitating both stronger FoxA1 binding and stronger androgen responsiveness, due to the A allele forming a more perfect FoxA1/HNF3? binding site than the T allele. Nearby [[rs6983267]] is a succeptibility marker for [[prostate cancer]] and [[colon cancer]].
{{PMID Auto
|PMID=19680443
|Title=Functional enhancers at the gene-poor 8q24 cancer-linked locus
|OA=1
}}

{{PMID Auto
|PMID=22099997
|Title=Risk loci on chromosome 8q24 are associated with prostate cancer in northern Chinese men.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}